Thomas F. Baumert

Inserm — France

Medicine · Health Sciences

23h-index2.5kcitations53works1.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(35), Liver Disease Diagnosis and Treatment(21), Hepatitis B Virus Studies(20), Hepatocellular Carcinoma Treatment and Prognosis(7), MicroRNA in disease regulation(5)

Publications52 total

Hepatitis D Virus Pathogenesis: A Sense of Complications
Viruses·2026Open Access
Modèles dérivés de patients pour les maladies chroniques hépatiques et les cancers du foie : vers une médecine de précision
Bulletin de l Académie Nationale de Médecine·2026
Hepatitis B virus-infected hepatocytes promote the secretion of collagen VI to the extracellular matrix
Scientific Reports·2025Open Access
Improving risk stratification and detection of early HCC using ultrasound-based deep learning models
JHEP Reports·2025· 1 citedOpen Access
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models
npj gut and liver.·2025· 8 citedOpen Access
Mammary tumor development induces perturbation of liver glucose metabolism with inflammation and fibrosis
American Journal of Physiology-Endocrinology and Metabolism·2025· 1 citedOpen Access
IL-22 regulates MASTL expression in intestinal epithelial cells
American Journal of Physiology-Gastrointestinal and Liver Physiology·2024· 3 citedOpen Access
Physiomimetic In Vitro Human Models for Viral Infection in the Liver
Seminars in Liver Disease·2022· 4 citedOpen Access
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
BMC Infectious Diseases·2022· 12 citedOpen Access
Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies
Journal of Hepatology·2021· 97 citedOpen Access
Roadblocks and fast tracks: How RNA binding proteins affect the viral RNA journey in the cell
Seminars in Cell and Developmental Biology·2020· 59 citedOpen Access
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort
Clinics and Research in Hepatology and Gastroenterology·2020· 4 citedOpen Access
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
Gut·2020· 95 citedOpen Access
Radiomics in hepatocellular carcinoma: a quantitative review
Hepatology International·2019· 127 citedOpen Access
Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
Hepatology Communications·2019· 48 citedOpen Access
Mortality from liver cirrhosis and HCC in the DAA era: success in viral control is darkened by raise of metabolic disease
HepatoBiliary Surgery and Nutrition·2019· 5 citedOpen Access
Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity
Gut·2019· 35 citedOpen Access
Reply
Hepatology·2019
Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
Gut·2019· 48 citedOpen Access
Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection
Viruses·2016· 61 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Mirjam B. Zeisel(17), Catherine Schuster(10), Sébastien Pfeffer(7), Patrick Pessaux(5), Émilie Crouchet(5), Catherine Fauvelle(5), Éloi R. Verrier(5), Michel Doffoël(5), Laura Heydmann(5), Antonio Saviano(4), François Habersetzer(4), Che C. Colpitts(4), Joachim Lupberger(4), Isabel Fofana(4), Frank Jühling(3), Marine A. Oudot(3), Amélie Weiss(3), Laurent Brino(3), Si Nafa Si Ahmed(3), Daniel J. Felmlee(3)